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Editorial
Enhancing the JMD Experience
As The Journal of Molecular Diagnostics begins publication
of its tenth volume, our world is becoming increasingly
driven by the need for immediacy. We rely more heavily
on electronic communication and instant access to ac-
curate information. The Journal and its Editorial Board are
responding to this by increasing the frequency of publi-
cation, providing greater dissemination of the JMD, and
taking steps to ensure the integrity of the publication
process. All of these pursuits serve to enhance the ex-
perience of our authors and readers.
Foremost in our quest for greater enhancement is the
need to provide timely publication of accepted manu-
scripts. We have remained cognizant of this fact while
experiencing continual growth of submissions to the
Journal. Thus, we are pleased to announce that, begin-
ning with this issue, the JMD will be published six times
annually. This affords our authors with earlier exposure of
their research and gives our readers faster access to
data and results. Further, with our online publish-ahead-
of-print program, author-corrected article proofs are
posted to the JMD website (http://jmd.amjpathol.org/
papbyrecent.dtl) 4 to 8 weeks after final manuscript ac-
ceptance. This new feature, called JMDxpress, was suc-
cessfully launched last year. By providing a fully citable
version of the manuscript, we can establish earlier pub-
lication priority of articles. Also, using a version of the
article that has undergone preliminary copyediting and
author correction ensures the quality of the information.
Dissemination of information is the primary goal of any
publication, and the influence of electronic media has
resulted in the expectation that published research be
more readily available. The Journal is adapting by expand-
ing electronic publication of accepted articles. We have
partnered with PubMed Central to post published JMD
articles to their repository (http://www.pubmedcentral.
nih.gov/) for public access twelve months after print pub-
lication, which is the same point when articles become
freely accessible on the Journal site. This electronic pub-
lishing approach makes articles available as widely as
possible, thus increasing reader awareness and author
citations.
Successful scientific publishing requires that the integ-
rity of the reported data be guaranteed. This expectation
of honesty and integrity is held by three parties: the
readers, the Journal, and the authors. Readers trust that
articles published in JMD have undergone thorough, un-
biased review. The Journal also trusts its authors to sub-
mit studies that have been performed ethically. Likewise,
Authors trust the Journal to provide fair and timely peer
review of submitted manuscripts. In a committed effort to
safeguard these relationships, the Journal has produced
a formal Scientific Integrity Policy (http://jmd.amjpathol.
org/misc/integrity.shtml). As the publishers of JMD, the
Association for Molecular Pathology and the American
Society for Investigative Pathology vetted and approved
the policy, which defines expectations for Journal review-
ers, Editors, and staff in the peer-review process. Authors
are also clearly instructed on authorship criteria, conflicts
of interest, and research misconduct—such as falsifica-
tion of data and images, plagiarism, redundant publica-
tion, and ethical conduct of research subjects. When
concerns do arise, the process for addressing them is
clearly outlined, including guidelines for evaluating allega-
tions and addressing findings of misconduct. Concomi-
tantly, we have updated and revised our Instructions to
Authors (http://jmd.amjpathol.org/misc/ifora.shtml) and In-
structions to Reviewers (http://jmd.amjpathol.org/misc/for
Reviewers.shtml).
All in all, we are committed to growing and improving
The Journal of Molecular Diagnostics by enhancing the
value of published articles. We encourage our audience
to continue to support the Journal by submitting quality
manuscripts that advance the field of molecular diagnos-
tics. Current article categories include Regular Articles,
Technical Advances, Reviews, and case-oriented Con-
sultations in Molecular Diagnostics, and we encourage
authors to establish a dialogue surrounding key or con-
troversial issues by submitting Letters to the Editor. We in
turn will continue our commitment to quality scientific
publishing by seeking new methods of improving the
reader and author experience.
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